Langerhans cell histiocytosis (LCH) has previously been reported in association with other malignancies. The pathogenesis of LCH and its relationship to other malignancies is poorly understood. We present a novel case of a child who developed an LCH bone lesion while receiving a Phase I protocol therapy with oral fenretinide/Lym-X-Sorb (4-HPR/LXS) powder for neuroblastoma.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1002/pbc.22200 | DOI Listing |
Publication Analysis
Top Keywords
langerhans cell
8
cell histiocytosis
8
histiocytosis patient
4
patient stage
4
stage neuroblastoma
4
neuroblastoma receiving
4
receiving oral
4
oral fenretinide
4
fenretinide langerhans
4
histiocytosis lch
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!